Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × Dexamethasone × Clear all

NCT00410956 2024-12-10

Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery

Phase 2 Completed

22 enrolled 12 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms